Advanced hepatocellular carcinoma
Okazaki, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 417-421
2001
ISSN/ISBN: 0047-1852 PMID: 11761984 Document Number: 538051
Document emailed within 1 workday
Related Documents
Huang, W.; You, L.; Liu, D.; Yang, S.; Liu, M.; Wang, H.; Wang, P.; Baikere, P.; Gu, P.; Abulikemu, A.; Yuan, S.; Fan, X. 2016: S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma Journal of BUON: Official Journal of the Balkan Union of Oncology 21(6): 1388-1393Usatoff, V.; Isla, A.M.; Habib, N.A. 2001: Liver resection in advanced hepatocellular carcinoma Hepato-Gastroenterology 48(37): 46-50
Seki, S.; Yamada, T.; Kawakita, N.; Masuichi, H.; Kitada, T.; Sakaguchi, H. 2003: A new chemotherapeutic regimen for advanced unresectable hepatocellular carcinoma Hepato-Gastroenterology 50(53): 1598-1602
Li, J.; Wang, L.; Cong, N.; Shi, C.; Bu, W.; Song, J.; Chen, H. 2014: Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors Hepato-Gastroenterology 61(132): 954-957
Sakai, M.; Hibi, K.; Kanazumi, N.; Nomoto, S.; Inoue, S.; Takeda, S.; Nakao, A. 2005: Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma Hepato-Gastroenterology 52(66): 1854-1857
Kuzuya, T.; Tsuchiya, K.; Izumi, N. 2010: Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1883-1886
Liang, L.J. 1992: Two-stage resection for advanced hepatocellular carcinoma--preliminary results of 13 cases Zhonghua Zhong Liu Za Zhi 14(6): 449-451
Nakamura, H.; Kawata, S.; Takamura, M.; Osuga, K.; Murakami, T. 2000: Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(10): 1509-1515
Miyagawa, H.; Kamioka, N.; Kohara, H.; Yuube, R.; Takahashi, T.; Nakatoh, H.; Kawada, M.; Utsunomiya, T.; Izumiyama, F.; Akimori, T. 1993: A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2211-2215
Alvarez, R.; Bañares, R.; Echenagusía, A.; Carneros, J.A.; Santos, L.; Simó, G.; Camúñez, F. 2000: Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma Gastroenterologia y Hepatologia 23(4): 153-158
Yoshikawa, M.; Ebara, M.; Fukuda, H.; Sugiura, N.; Saisho, H. 1998: Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(Suppl 1): 30-33
Tu, J.; Ji, J.; Wu, F.; Zhang, D.; Ying, X.; Zhao, Z. 2014: Efficacies of ¹³¹I-chTNT plus radiofrequency ablation for the treatment of advanced hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 94(45): 3586-3588
Bedenne, L.; Chauffert, B.; Lorcerie, B.; Faivre, J.; Hillon, P.; Klepping, C.; Martin, F. 1989: Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil Gastroenterologie Clinique et Biologique 13(10): 845-846
Yamamoto, M.; Fujii, H. 1995: Optimal locoregional immunochemotherapy after tumor-mass reduction for advanced hepatocellular carcinoma Hepato-Gastroenterology 42(5): 567-577
Motohara, T.; Ozawa, Z.; Morita, S. 1994: Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(15): 2645-2648
Carr, B.I.; Selby, R.; Madariaga, J.; Iwatsuki, S.; Starzl, T.E. 1993: Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma Transplantation Proceedings 25(1 Pt 2): 1128-1129
Murata, T.; Uda, M.; Nagata, K.; Harima, K.; Nishida, T.; Kawa, S.; Oshima, T.; Tanaka, Y.; Okuda, M.; Seki, Y. 1994: Clinical study of cyclic intra-arterial chemotherapy using mitoxantrone for advanced hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(12): 1991-1996
Tongsiri, N.; Subwongcharoen, S.; Treepongkaruna, S.-a. 2017: The Impact of Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinoma: a Single Center Experience Journal of the Medical Association of Thailand 100(1): 33-41
Masutani, S.; Shimizu, J.; Tatsuta, M.; Masuda, F.; Imamura, H.; Ishida, H.; Furukawa, H.; Tomotsu, K.; Yura, M.; Obana, T.; Kitamura, S.; Saeki, N.; Inoue, Y.; Takamura, M.; Ohnishi, H. 2003: Long-term outcome of advanced hepatocellular carcinoma that received transarterial hepatic chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1579-1582
Baba, H.; Tanaka, K.; Oba, A.; Fujiwara, N.; Nakamura, H.; Kuwabara, H.; Tamai, S.; Nakajima, K.; Goseki, N. 2009: A case of hepatocellular carcinoma with advanced gastric cancer treated by radio frequency ablation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2365-2367